Go Back Up
Promotional impact

White Paper: Patient chart audits

Beyond What Was Prescribed

What AI-powered conversational chart audits reveal across UC (Ulcerative Colitis), HS (Hidradenitis Suppurativa), and MM (Multiple Myeloma) — and what that intelligence is worth to brand teams making commercial decisions.

Read The Findings

Get the whitepaper

Complete the form to download the whitepaper "FREE" and See how conversational AI uncovers the “why” behind decisions in UC, HS, and Multiple Myeloma.

Get Faster, Deeper Insights

From Prescriptions to Physician Reasoning

Uncover the physician reasoning shaping Ulcerative Colitis, Hidradenitis Suppurativa and Multiple Myeloma—and what it means for your brand strategy
 
Most pharma insight teams believe their patient chart audits are working. The problem is rarely the data itself — it’s what the data was never designed to capture. This white paper presents verbatim clinical findings from conversational AI-powered chart audits across three competitive therapeutic areas. Every finding is physician-spoken. Every commercial implication is specific.  
 
What You’ll Learn
 
  • Why Skyrizi is being passed over in UC — and it’s not about efficacy.
  • How Bimzelx physicians describe adoption in their own words, and what that reveals about commercial strategy in HS.
  • What hematologists are saying about Dara+Tec 12 months before approval — and how 1L DARA exposure is already constraining the 2L market.
  • Why traditional PCAs are structurally incapable of surfacing this intelligence.

 

From Skyrizi access dynamics in UC to Bimzelx adoption in HS and early positioning signals in MM—these are insights traditional audits fail to surface. Download the whitepaper to uncover the intelligence shaping real-world prescribing decisions. 

 

Who we are

ZoomRx Patient Chart Audits

Next Generation Healthcare Intelligence powered by Patient Scribe

ZoomRx helps pharma and biotech teams uncover real-world treatment insights faster and at scale. Our AI-powered, conversational patient chart audits replace rigid surveys with engaging experiences that deliver richer clinical context in weeks—not months. Trusted by top-20 pharmaceutical companies, ZoomRx combines advanced AI with deep therapeutic expertise to turn real-world data into confident, actionable decisions. 

LEARN MORE